First Tracks Biotherapeutics Inc

NASDAQ:TRAX

Biotechnology

Healthcare
$43.57 -4.87%

-$0.89 today

Market cap
$1.83B
Beta
0.00
P/E (TTM)
-6.1
EPS (TTM)
-$2.81
52W Low $14.72High $26.80

Volume 0.59M

Average 0.43M

Price history

First Tracks Biotherapeutics Inc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+129.32%

Period high

$52.33

Period low

$15.32

Latest

$43.57

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 12, 2026Nov 12, 2026
SC 13G/ANov 6, 2026Nov 6, 2026
424B3Nov 4, 2026Nov 4, 2026
424B3Nov 4, 2026Nov 4, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
10-QNov 3, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
EFFECTOct 29, 2026Oct 30, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
S-1Oct 26, 2026Oct 26, 2026
8-KOct 20, 2026Oct 20, 2026
8-KOct 15, 2026Oct 15, 2026

Competitors

Who does First Tracks Biotherapeutics Inc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about TRAX's filings, answered from its disclosures.

What is the latest TRAX filing?

The latest filing shown is SC 13G dated Nov 12, 2026.

How many recent filings does TRAX have?

Intrinsic Alpha currently shows 20 recent filings for TRAX.